BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 16448320)

  • 1. Evolving treatment strategies for chronic refractory angina.
    Yang EH; Barsness GW
    Expert Opin Pharmacother; 2006 Feb; 7(3):259-66. PubMed ID: 16448320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current and future treatment strategies for refractory angina.
    Yang EH; Barsness GW; Gersh BJ; Chandrasekaran K; Lerman A
    Mayo Clin Proc; 2004 Oct; 79(10):1284-92. PubMed ID: 15473411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment options for refractory angina in patients who are not candidates for revascularization.
    Conti CR
    Curr Cardiol Rep; 2006 Jul; 8(4):272-6. PubMed ID: 16883657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic stable angina pectoris.
    Jawad E; Arora R
    Dis Mon; 2008 Sep; 54(9):671-89. PubMed ID: 18725007
    [No Abstract]   [Full Text] [Related]  

  • 5. Management of refractory angina pectoris.
    Manchanda A; Aggarwal A; Aggarwal N; Soran O
    Cardiol J; 2011; 18(4):343-51. PubMed ID: 21769814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New agents for the therapy of angina pectoris].
    Meinertz T; Köster R
    Internist (Berl); 2011 Jul; 52(7):894-6, 898-900. PubMed ID: 21713611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel therapeutic approaches to treating chronic angina in the setting of chronic ischemic heart disease.
    Chaitman BR; Sano J
    Clin Cardiol; 2007 Feb; 30(2 Suppl 1):I25-30. PubMed ID: 18373327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of ranolazine in chronic stable angina patients.
    Patel PD; Arora RR
    Vasc Health Risk Manag; 2008; 4(4):819-24. PubMed ID: 19065998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conventional and novel drug therapeutics to relief myocardial ischemia.
    Dvir D; Battler A
    Cardiovasc Drugs Ther; 2010 Aug; 24(4):319-23. PubMed ID: 20658184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The evolving role of medical therapy for chronic stable angina.
    Eid F; Boden WE
    Curr Cardiol Rep; 2008 Jul; 10(4):263-71. PubMed ID: 18611360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Update coronary artery disease: important progresses in acute and chronic therapy].
    Athanasiadis A; Sechtem U
    MMW Fortschr Med; 2012 Mar; 154(5):58-60. PubMed ID: 22624267
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of ivabradine and ranolazine in patients with microvascular angina pectoris.
    Villano A; Di Franco A; Nerla R; Sestito A; Tarzia P; Lamendola P; Di Monaco A; Sarullo FM; Lanza GA; Crea F
    Am J Cardiol; 2013 Jul; 112(1):8-13. PubMed ID: 23558043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of stable angina pectoris.
    Palaniswamy C; Aronow WS
    Am J Ther; 2011 Sep; 18(5):e138-52. PubMed ID: 20861717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of a metabolic modulator drug in chronic stable angina: review of evidence from clinical trials.
    Chaitman BR
    J Cardiovasc Pharmacol Ther; 2004 Sep; 9 Suppl 1():S47-64. PubMed ID: 15378131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical therapy versus myocardial revascularization in chronic coronary syndrome and stable angina.
    Deedwania PC; Carbajal EV
    Am J Med; 2011 Aug; 124(8):681-8. PubMed ID: 21787900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the Antianginal Drugs Ranolazine, Nicorandil, and Ivabradine on Coronary Microvascular Function in Patients With Nonobstructive Coronary Artery Disease: A Meta-analysis of Randomized Controlled Trials.
    Zhu H; Xu X; Fang X; Zheng J; Zhao Q; Chen T; Huang J
    Clin Ther; 2019 Oct; 41(10):2137-2152.e12. PubMed ID: 31548105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
    Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
    JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-PCI/CABG therapies for refractory angina.
    Park KE; Conti CR
    Trends Cardiovasc Med; 2018 Apr; 28(3):223-228. PubMed ID: 29157949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angina and Its Management.
    Kloner RA; Chaitman B
    J Cardiovasc Pharmacol Ther; 2017 May; 22(3):199-209. PubMed ID: 28196437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ranolazine and other antianginal therapies in the era of the drug-eluting stent.
    Berger P
    JAMA; 2004 Jan; 291(3):365-7. PubMed ID: 14734600
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.